SG Americas Securities »

Aerovate Therapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $23k 11k 2.09
2024-06-30 $298k 180k 1.66

More positions owned by SG Americas Securities

Apple (AAPL)
Facebook Inc cl a (META)
Spdr S&p 500 Etf (SPY)
Broadcom (AVGO)
Alphabet Inc Class A cs (GOOGL)
Visa (V)
UnitedHealth (UNH)
Alphabet Inc Class C cs (GOOG)
Invesco Qqq Trust Series 1 (QQQ)
iShares S&P 500 Index (IVV)
Progressive Corporation (PGR)
Vanguard S&p 500 Etf idx (VOO)
United Parcel Service (UPS)
SPDR Gold Trust (GLD)
Palo Alto Networks (PANW)

View all positions for SG Americas Securities

Top funds holding Aerovate Therapeutics

RA Capital Management
Sofinnova Ventures
TCG Crossover Management
Atlas Venture Life Science Advisors
Deerfield Management Company
Vanguard Group
BlackRock
BlackRock
Baker Bros. Advisors
Affinity Asset Advisors
Octagon Capital Advisors
Opaleye Management
GSA Capital Partners
Ikarian Capital
Acadian Asset Management

View all funds holding Aerovate Therapeutics